Antagonising neuromuscular block at the end of surgery

BMJ (Online)

Volumn 345, Issue 7880, 2012, Pages

  Hunter, Jennifer M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; CHOLINESTERASE INHIBITOR; MORPHINE; MUSCLE RELAXANT AGENT; NEOSTIGMINE; NITROUS OXIDE; PANCURONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHESIA MECHANISM; ANESTHETIC RECOVERY; CLINICAL ASSESSMENT; CLINICAL COMPETENCE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIAPHRAGM PARALYSIS; EDITORIAL; HUMAN; LUNG COMPLICATION; NEUROMUSCULAR BLOCKING; OXYGENATION; PATIENT MONITORING; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY ASPIRATION; RESPIRATORY TRACT DISEASE; SLEEP INDUCTION; SURVIVAL;

FEMALE; HUMANS; MALE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; RESPIRATORY INSUFFICIENCY;

EID: 84868018439     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e6666     Document Type: Editorial

References (12)

1. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345:e6329.
2. Gray TC, Halton J. A milestone in anaesthesia? (d-Tubocurarine chloride). Proc R Soc Med 1946; 34:400-10.
3. Beecher HK, Todd DP. A study of deaths associated with anesthesia and surgery. Ann Surg 1954; 140:2-33.
4. Gray TC, Wilson F. The development and use of muscle relaxants in the United Kingdom. Anesthesiology 1959; 20:519-29.
5. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarisation in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-5.
6. Debaene B, Plaud B, Dilly M-P, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-8.
7. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised and blinded study of postoperative complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-103.
8. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-7.
9. Arbous MS, Meursing AEE, van Kleef JW, de Lange J, Spoormans HHAJM, Touw P, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102:257-68.
10. Viby-Mogensen J. Postoperative residual curarisation and evidence-based anaesthesia. Br J Anaesth 2000; 84:301-3.
11. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98:302-16.
12. McCaul C, Tobin E, Boylan JF, McShane AJ. Atracurium is associated with postoperative residual curarisation. Br J Anaesth 2002; 89:766-9.